Indivior Pharmaceuticals, Inc. (INDV)
33.46
-0.40
(-1.18%)
USD |
NASDAQ |
Feb 10, 16:00
33.46
0.00 (0.00%)
After-Hours: 20:00
Indivior Pharmaceuticals EPS Diluted (Quarterly) : 0.3256 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 1.259 |
| Amicus Therapeutics, Inc. | 0.0558 |
| Apyx Medical Corp. | -0.0487 |
| Viatris, Inc. | -0.1101 |
| Owlet, Inc. | 0.1338 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 42.00M |
| Revenue (Quarterly) | 314.00M |
| Total Expenses (Quarterly) | 272.00M |
| Enterprise Value | 4.094B |
| Gross Profit Margin (Quarterly) | 80.25% |
| Profit Margin (Quarterly) | 13.38% |
| Earnings Yield | 3.00% |
| Operating Earnings Yield | 7.88% |
| Normalized Earnings Yield | 4.797 |